ImmunityBio (IBRX) Return on Equity [ROE] (2015 - 2019)
ImmunityBio (IBRX) recorded Return on Equity [ROE] of -210.34% in Q4 2019, down 131.48 percentage points from -78.86% a year earlier and down 163.35 percentage points from the prior quarter.
ImmunityBio (IBRX) Return on Equity [ROE] (2015 - 2019) Analysis & Trends
For FY2019, ImmunityBio reported Return on Equity [ROE] of -325.96%, down 261.98 percentage points from FY2018.
- Annual Return on Equity [ROE] has declined for three straight years, with a five-year change of -302.98 percentage points (FY2014 to FY2019).
- Across earlier years, Return on Equity [ROE] came in at -63.98% in FY2018 (-26.34 pp), -37.65% in FY2017 (-0.44 pp), -37.21% in FY2016 (+77.34 pp) and -114.55% in FY2015 (-91.57 pp).
- The Q4 2019 figure is the lowest quarterly Return on Equity [ROE] in data going back to Q3 2015.
- On a year-over-year basis, Return on Equity [ROE] rose in two of the last eight quarters, with an average year-over-year change of -26.66 percentage points.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 48.28 percentage points in Q3 2016, against a drop of 131.48 percentage points in Q4 2019 at the low end.
- Per Business Quant, the preceding three quarters came in at -46.99% (Q3 2019), -47.35% (Q2 2019) and -69.34% (Q1 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | ImmunityBio | 10.83 Bn | 9.59 Bn | 50.94 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | -210.34% |
| Sep 30, 2019 | -46.99% |
| Jun 30, 2019 | -47.35% |
| Mar 31, 2019 | -69.34% |
| Dec 31, 2018 | -78.86% |
| Sep 30, 2018 | -60.15% |
| Jun 30, 2018 | -54.30% |
| Mar 31, 2018 | -47.44% |
| Dec 31, 2017 | -42.24% |
| Sep 30, 2017 | -39.20% |
| Jun 30, 2017 | -39.19% |
| Mar 31, 2017 | -40.10% |
| Dec 31, 2016 | -39.98% |
| Sep 30, 2016 | -38.67% |
| Jun 30, 2016 | -41.02% |
| Mar 31, 2016 | -67.01% |
| Dec 31, 2015 | -65.90% |
| Sep 30, 2015 | -86.95% |
ImmunityBio Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IBRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();